Stryker Reconstructive Business Sales Drop 1.1% FeaturedWritten by Jaimie Oh | October 18, 2012
Stryker has reported $781 million in quarterly sales for its reconstructive business line, down 1.1 percent compared to the same quarter last year.
Although the medical device company saw higher unit volumes, these gains were offset by unfavorable changes in price and foreign currency exchange rates. Stryker saw an overall sales gain of 1 percent totaling $2.1 billion for this quarter.
© Copyright ASC COMMUNICATIONS 2011. Interested in LINKING to or REPRINTING this content? View our policies here.